| 0.0001 -0 (-50%) | 11-28 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0 | 1-year : | 0 |
| Resists | First : | 0 | Second : | 0 |
| Pivot price | 0  |
|||
| Supports | First : | 0 | Second : | 0 |
| MAs | MA(5) : | 0 | MA(20) : | 0 |
| MA(100) : | 0  |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 100 | D(3) : | 100 |
| RSI | RSI(14): 70.5 | |||
| 52-week | High : | 0.01 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MOTS ] has closed below upper band by 37.5%. Bollinger Bands are 21% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0 - 0 | 0 - 0 |
| Low: | 0 - 0 | 0 - 0 |
| Close: | 0 - 0 | 0 - 0 |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Wed, 31 Jul 2024
Motus GI Holdings Initiates Board Reshuffle and Wind-Down Process - TipRanks
Wed, 31 Jul 2024
Motus GI announces board resignations and business wind-down - Investing.com
Thu, 20 Jun 2024
Motus GI faces default notice after board decision - Investing.com
Wed, 17 Apr 2024
MOTS Stock Price and Chart — OTC:MOTS - TradingView
Tue, 19 Dec 2023
Molina (MOH) to Pay Lower Price for California Medicare Buyout - Yahoo Finance
Mon, 18 Dec 2023
Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | -4 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 6.39e+006 (%) |
| Held by Institutions | 5.72e+006 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.97 |
| Profit Margin | 0 % |
| Operating Margin | -3 % |
| Return on Assets (ttm) | 165.6 % |
| Return on Equity (ttm) | -62.1 % |
| Qtrly Rev. Growth | 69 % |
| Gross Profit (p.s.) | -27.54 |
| Sales Per Share | -302.9 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -9.14e+006 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -0.01 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0 |
| Dividend | 23240 |
| Forward Dividend | 80930 |
| Dividend Yield | 11620000000% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|